Targeting GPCRs with Agonistic Antibodies: A New Frontier in Obesity Treatment
Time: 10:00 am
day: Conference Day One
Details:
- Discovery of novel agonistic VHH using ConfoGen Technology
- Structure of agonistic VHH in complex with GPCR
- In Vivo efficacy and selectivity with highly potent agonistic VHH
